Currently Viewing:
Psych Congress 2018
Considerations for Clinicians Looking to Advise Patients About Cannabis
October 25, 2018
Dr W. Clay Jackson on the Prevalence of Clinician Burnout
October 25, 2018
Dr Mark Zimmerman on How Depression Severity Is Measured
October 25, 2018
Challenges of Treating Postpartum Depression
October 26, 2018
Dr Michael Thase Discusses Treating Major Depressive Disorder
October 26, 2018
Dr Joseph McEvoy Outlines Barriers to Mitigating Internal Stigma Surrounding Mental Illness
October 26, 2018
Survey of Patients With Depression Finds Many Say Antidepressants Unhelpful
October 27, 2018
Depression: Not an Inflammatory Disease, but Inflammation Plays a Huge Role
October 27, 2018
As Hurricanes, Shootings Rise, Psychiatrist Discusses Mental Health in the Aftermath
October 27, 2018
Should Antidepressants Be Used in Bipolar Depression? A Pro-Con Debate
October 28, 2018
Ten Drug Combinations That Show the Risks of Psychiatric Polypharmacy
October 28, 2018
Phase 3 Study of ALKS 3831 Indicates Schizophrenia Drug Shows Benefit
October 28, 2018
Dr Michael First: Challenges With Correctly Diagnosing ADHD, Bipolar Disorder
October 28, 2018
Dr John Kane on the Importance of Patient, Family Engagement in Schizophrenia
October 28, 2018
Psychiatrist With Multiple Relatives With Autism Shares Treatment Journey
October 29, 2018
Currently Reading
Dr Michael Thase on the Prevalence of Stigma Surrounding Major Depressive Disorder
November 19, 2018
Dr W. Clay Jackson: Clinician Burnout Impacts Both Personal and Patient Outcomes
December 02, 2018
Dr Michael Thase Outlines Developments in the Pathophysiology of Major Depressive Disorder
December 05, 2018
Dr W. Clay Jackson Discusses Identifying, Addressing Clinician Burnout
December 18, 2018
Dr Michael Thase: Patient Characteristics, Biomarkers That Guide Treatment for MDD
December 21, 2018

Dr Michael Thase on the Prevalence of Stigma Surrounding Major Depressive Disorder

Stigma is less prevalent now than it was 20 or 30 years ago, but people still often equate depression with weakness, explained Michael Thase, MD, professor of psychiatry and director of the Mood and Anxiety Program at the University of Pennsylvania.


Stigma is less prevalent now than it was 20 or 30 years ago, but people still often equate depression with weakness, explained Michael Thase, MD, professor of psychiatry and director of the Mood and Anxiety Program at the University of Pennsylvania.

Transcript

How prevalent is stigma surrounding major depressive disorder?


I think stigma is less prevalent today than it was 20 or 30 years ago, and there have been efforts, including the National Institute of Mental Health’s DART [Depression Awareness, Recognition and Treatment] Program in the 1980s and 1990s. I think efforts of the pharmaceutical industry through director-to-consumer advertisement is one way of kind of making treatments that are known to work more known to our patients.

Nevertheless, people often still equate the term depression with weakness and believe strategies like pulling yourself up by your boot straps or simply not telling anyone about it and hoping it will go away will be remedies. Because some episodes of depression do remit without treatment—the spontaneous remission rates are maybe as high as 30% or 40% across a year. People, if they do wait and see or just hope, sometimes do get better. But, each month you suffer with depression, each month it goes untreated, your kids suffer, your job suffers because depression is the largest cause of presenteeism and absenteeism in the workplace.

So, the impact of the illness tends to build, and in the long run, that makes it harder to treat.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up